1,478 results on '"Wörmann, B"'
Search Results
2. Haarzellleukämie
3. Fortschritte in der Onkologie zeitnah und kritisch umsetzen: Interview mit Prof. Dr. med Bernhard Wörmann, Medizinischer Leiter der Deutschen Gesellschaft für Hämatologie und Medizinische Onkologie (DGHO)
4. Metastasiertes Prostatakarzinom: Aktuelle Daten, neue Therapieoptionen und Therapiemonitoring
5. Randomized Comparison of Sequential High-Dose Cytosine Arabinoside and Idarubicin (S-HAI) with or without Chemo-Modulation by Fludarabine in Refractory and Relapsed Acute Myeloid Leukemia
6. Multivariate Analysis of Prognostic Factors in Patients with Refractory and Relapsed Acute Myeloid Leukemia Undergoing Sequential High-Dose Cytosine Arabinoside and Mitoxantrone (S-HAM) Salvage Therapy: Significance of Cytogenetic Abnormalities
7. Modulation of AraC by Fludarabine: Results of Salvage Therapy by AMLCG
8. MLL-Duplications are Rare and Associated with Poor Prognosis in Acute Myeloid Leukemia
9. Analysis of the Apoptotic Signal Transduction Cascade and New Differentially Expressed Genes in Drug Resistant and Sensitive Hematopoetic Cell Lines
10. The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO)
11. G-CSF Increases the Number of Trisomy 8 Metaphases in Vitro in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome
12. The Prognostic Impact of Trisomy 8 in Acute Myeloid Leukemia: Do Accompanying Aberrations Influence Prognosis?
13. Hematopoietic Growth Factors: Supportive and Priming Effects in AML
14. The Karyotype in MDS — Cytogenetic Profile, Clinical Correlations and Prognostic Implications in 362 Patients with MDS
15. Failure of Fluconazole Prophylaxis to Reduce Mortality During Treatment for Refractory Acute Myeloid Leukemia: Results of a Phase III Multicenter Study
16. Detection Limits of Malignant Cells with Leukemia-Associated Phenotype (LAP) in Acute Myeloid Leukemia
17. Clonal Chromosomal Abnormalities in the Stem Cell Compartment of a Patient with Acute Myeloid Leukemia in Hematological Complete Remission
18. Granulocyte Colony-Stimulating Factor Improves the Antileukemic Efficacy of the Sequential High-Dose Cytosine Arabinoside and Mitoxantrone Regimen (S-HAM) in Patients Younger than 60 Years with High-Risk Acute Myeloid Leukemia
19. Superiority of High-Dose over Intermediate-Dose Cytosine Arabinoside (AraC) in the Treatment of Patients with High-Risk Acute Myeloid Leukemia (AML)
20. Treatment of Relapsed and Refractory Acute Myeloid Leukemias — Strategies of the German AML Cooperative Group (AMLCG)
21. All-Trans Retinoic Acid (ATRA) Combined with Double Induction Strategy in Acute Promyelocytic Leukemia (APL). Preliminary Results
22. Biologic Determinants for AML Therapy
23. Involvement of CD34+ Stem Cells in Malignant Transformation in AML and MDS — Genetic Analysis of Sorted Subpopulations by Classical and Molecular Cytogenetics
24. Functional Characterization of Leukemic Stem Cells in Acute Myeloid Leukemia
25. Growth Factors in AML: Updates
26. Fludarabine and Fludarabine, Mitoxantrone, Dexamethasone in the Management of Low-Grade Non-Hodgkin Lymphomas
27. Detection of Minimal Residual Disease in Cytogenetically Defined Prognostic Subgroups of AML
28. Correlation of Deoxycytidine Deaminase, Thymidine Kinase and Polymerase Alpha Activity and Deoxycytidine Deaminase Gene Expression In Vivo with Clinical Response to TAD-9+GM-CSF Induction Therapy in Acute Myeloid Leukemia
29. Characterization of Normal and Leukemic Lymphohematopoietic Precursor Cells by Three-Color Flow Cytometry and Detection of Clone-Specific Leukemia-Associated T-Cell Receptor δ Rearrangements
30. IFN-α Is an Inhibitory Cytokine of Leukemic B-Cell Precursors
31. Therapy of Sepsis Syndrome with Human Polyclonal IgM-Enriched Immunoglobulins: Interim Analysis of a Randomized Trial in Neutropenic Cancer Patients
32. Genetic Instability and Evolution of Karyotype in Secondary Acute Myeloid Leukemia
33. Preliminary Results of a Placebo-Controlled, Double-Blind Trial Evaluating Sequential HD-AraC/Mitoxantrone Induction Chemotherapy with or Without Granulocyte-Macrophage Colony-Stimulating Factor in Patients with High-Risk Myelodysplastic Syndromes
34. Chromosome Abnormalities and Karyotype Evolution in the Stem Cell Compartments of AML and MDS
35. Comparison of Flask and Bag Systems in Cultivation of Dendritic Cells for Clinical Application
36. Interleukin-2 Postremission Therapy in Acute Myeloid Leukemia (AML): In Vitro and In Vivo Effects of a Five Day Continuous Infusion of IL-2 on Phenotype and Function of Peripheral Lymphocytes
37. S-HAM Salvage Therapy of Relapsed and Refractory AML Followed by Interleukin 2 Postremission Therapy
38. Hematopoietic Recovery and Priming — Therapeutic Effects of GM-CSF in the Treatment of AML
39. Hematologic and Therapeutic Effects of High-Dose AraC/Mitoxantrone (HAM) in the Induction Treatment of Patients with Newly Diagnosed AML. A Trial by AML Cooperative Group
40. Fludarabine in Combination with Mitoxantrone and Dexamethasone in Relapsed and Refractory Low-Grade Non-Hodgkin’s Lymphoma
41. Heterogeneity of HRX-FEL Fusion Transcripts in Adult and Pediatric t(4;11) ALL
42. CD34 and CD38 Expression on Blasts in Myelodysplastic Syndromes and Secondary AML
43. Age, not therapy intensity, determines outcomes of adults with acute myeloid leukemia
44. Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia
45. Modulation of Intracellular Ara-C Metabolism in AML Blasts by GM-CSF
46. Effects on Ara-C Cytotoxicity for AML Colony Forming Cells By Priming With rhGM-CSF and rhIL-3 In Vitro and In Vivo
47. GM-CSF in Chemotherapy for Newly Diagnosed AML: Multiple Course Priming and Longterm Administration Compared to Chemotherapy Alone
48. Significance of Lineage-Associated Transcripts of TdT and ETS1 for Detection of Leukemic Cells
49. Characterization of Clonal Gene Rearrangements for the Detection of Residual Leukemic Disease in Acute Lymphoblastic Leukemia
50. Prospective Study on the Clinical Relevance of Residual Disease in Patients with Acute Myeloid Leukemia in Complete Remission
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.